Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma

Journal of Research in Medical Sciences

Volumn 14, Issue 4, 2009, Pages 239-247

  Zali, Mohammad Reza ^a   Moaven, Omeed ^b   Aghdaee, Hamid Asadzadeh ^a   Ghafarzadegan, Kamran ^c   Ahmadi, Khadijeh Jami ^b   Farzadnia, Mehdi ^d   Arabi, Azadeh ^b   Abbaszadegan, Mohammad Reza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

catenin; E cadherin; Gastric cancer; Immunohistochemistry; p53

Indexed keywords

BETA CATENIN; PROTEIN P53; UVOMORULIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL MEMBRANE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DYSPLASIA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 70449732589     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005;6(3):359-363
2. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56(1):1-9. (Pubitemid 36183309)
3. Demetter P, De Vos M, Van Damme N, Baeten D, Elewaut D, Vermeulen S, et al. Focal up-regulation of Ecadherin- catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. Am J Clin Pathol 2000;114(3):364-370 (Pubitemid 33049671)
4. Karayiannakis AJ, Syrigos KN, Chatzigianni E, Papanikolaou S, Karatzas G. E-cadherin expression as a differentiation marker in gastric cancer. Hepatogastroenterology 1998;45(24):2437-2442 (Pubitemid 29055852)
5. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherence junctions. Annu Rev Cell Dev Biol 1997;13:119-146 (Pubitemid 28034522)
6. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer 1996;77(8 Suppl):1605-1613 (Pubitemid 26111841)
7. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14(15):1837-1851
8. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P. The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J Biol Chem 1995;270(10):5549-5555
9. Nakatsuru Sh, Yanagisawa A, Ichii Sh, Tahara E, Kato Y, Nakamura Y, et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992;1(8):559-563
10. Roa JC, Anabalón L, Roa I, Tapia O, Melo A, Villaseca M, et al. Promoter methylation profile in gastric cancer. Rev Med Chil 2005;133(8):874-880 (Pubitemid 41602683)
11. Ilyas M, Tomlinson IPM. The interactions of APC, E-cadherin and β-catenin in tumor development and progression. J Pathol 1997;182(2):128-137 (Pubitemid 27287832)
12. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991;139(1):17-23.
13. Shiozaki H, Iihara K, Oka H, Kadowaki T, Matsui S, Gofuku J, et al. Immunohistochemical detection of alphacatenin expression in human cancers. Am J Pathol 1994;144(4):667-674 (Pubitemid 24172055)
14. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142(4):987-993 (Pubitemid 24060574)
15. Inada S, Koto T, Futami K, Arima S, Iwashita A. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surg Today 1999;29(6):493-503. (Pubitemid 29313958)
16. Lou P, Chen W, Sheen T, Ko J, Hsu M, Wu J. Expression of E-cadherin/catenin complex in nasopharyngeal carcinoma: correlation with clinicopathological parameters. Oncol Rep 1999;6(5):1065-1071
17. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherincatenin complex in gastric carcinoma: relationship with patient survival. Gastroenterol 1997;112(1):46-54. (Pubitemid 27008985)
18. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, et al. Inverse expression of S100A4 and Ecadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 2000;6(11):4234-4242 (Pubitemid 30840172)
19. Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Abnormal expression of E-cadherin and β-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg 2002;89(2):236-244 (Pubitemid 34124250)
20. Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001;13(3):332-337 (Pubitemid 32429498)
21. Okusa Y, Ichikura T, Tamakuma S. Immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in familial clustering of gastric cancer. J Surg Oncol 1996;62(4):253-257 (Pubitemid 26262348)
22. Starzynska T, Bromley M, Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;66(3):558-562
23. Gomyo Y, Ikeda M, Osaki M, Tatebe S, Tsujitani S, Ikeguchi M, et al. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 1997;79(11):2067-2072 (Pubitemid 27227370)
24. Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, et al .Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 1998;82(7):1238-1243 (Pubitemid 28155384)
25. Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K. Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma. Oncology 2002; 63(4):353-361 (Pubitemid 36151528)
26. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
27. Liu XP, Kawauchi S, Oga A, Suehiro Y, Tsushimi K, Tsushimi M, et al. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Histopathology 2001;39(6):603-610
28. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53(7):1690-1695 (Pubitemid 23113253)
29. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996;69(3):184-189 (Pubitemid 26233296)
30. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, et al. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002;8(6):987-993 (Pubitemid 35446407)
31. Huiping Ch, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S. Alterations of E-cadherin and β-catenin in gastric cancer. BMC Cancer 2001;1:16. (Pubitemid 38846503)
32. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994;125(6):1327-1340 (Pubitemid 24189536)
33. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, et al. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992;52(20):5770-5774
34. Birchmeier W. Cell adhesion and signal transduction in cancer. Conference on cadherins, catenins and cancer. EMBO Reports 2005;6(5):413-417
35. Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W. Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions. Genes Dev 2004;18(18):2225-2230 (Pubitemid 39209569)
36. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997;275(5307):1787-1790 (Pubitemid 27136715)
37. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997;275(5307):1790-1792 (Pubitemid 27136716)
38. Behrens J, Von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996;382(6592):638-642 (Pubitemid 26268958)
39. Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology 1999;34(5):410-415 (Pubitemid 29244165)
40. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992;52(24):6735-6740 (Pubitemid 23006271)
41. Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Letters 2003;201(1):97-106. (Pubitemid 37298002)
42. Wang L, Zhang F, Wu PP, Jiang XC, Zheng L, Yu YY. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma. World J Gastroenterol 2006;12(26):4228-4231 (Pubitemid 44376909)
43. Pinto-de-Sousa J, Silva F, David L, Leitao D, Seixas M, Pimenta A, et al. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology 2004;44(4):323-331 (Pubitemid 38491298)
44. Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, et al. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology 1999;57(2):131-137 (Pubitemid 29385491)
45. Mattioli E, Vogiatzi P, Sun A, Abbadessa G, Angeloni G, D'Ugo D, et al. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. J Cell Physiol 2007;210(1):183-191
46. Schneider BG, Hilsenbeck SG, Hensel CH, Pekkel V, Shelton CH, Rodriguez-Martinez HA, et al. P53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos. Virchows Arch 1994;424(2):187-193 (Pubitemid 24105562)
47. Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995;76(5):720-726
48. Hurlimann J, Saraga EP. Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis. Am J Surg Pathol 1994;18(12):1247-1253 (Pubitemid 24362438)
49. Fukunaga M, Monden T, Nakanishi H, Ohue M, Fukuda K, Tomita N, et al. Immunohistochemical study of p53 in gastric carcinoma. Am J Clin Pathol 1994;101(2):177-180 (Pubitemid 24061444)
50. Joypaul BV, Hopwood D, Newman EL, Qureshi S, Grant A, Ogston SA, et al. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994;69(5):943-946 (Pubitemid 24140680)
51. Kim KM, Lee A, Chae HS, Shim SI. Expression of p53 and NDP-K/nm23 in gastric carcinomas-association with metastasis and clinicopathologic parameters. J Korean Med Sci 1995;10(6):406-413
52. Roviello F, Marrelli D, Vindigni C, De Stefano A, Spina D, Pinto E. P53 accumulation is a prognostic factor in intestinal- type gastric carcinoma but not in the diffuse type. Ann Surg Oncol 1999;6(8):739-745 (Pubitemid 30013650)
53. Lee DY, Park CS, Kim HS, Kim JY, Kim YC, Lee S. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications. Appl Immunohistochem Mol Morphol 2008;16(1):13-18
54. Deveci MS, Deveci G. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma. Gastric Cancer 2007;10(2):112-116 (Pubitemid 46955939)
55. Sasano H, Date F, Imatani A, Asaki S, Nagura H. Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol 1993;24(6):584-589 (Pubitemid 23162224)
56. Gamboa-Dominguez A, Seidl S, Reyes-Gutierrez E, Hermannstadter Ch, Quintanilla-Martinez L, Busch R, et al. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol 2007;60:756-761 (Pubitemid 47056903)